Dean Falb,Vincent M. Isabella,Jonathan W. Kotula,Paul F. Miller,Yves Millet,Adam Fisher
申请号：
US15772289
公开号：
US20180312851A1
申请日:
2016.09.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, inhibiting inflammatory mechanisms in the gut, and/or tightening gut mucosal barrier function are disclosed.
